Denali Advisors’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTS
NCM
PCM
S
Denali Advisors's SRTS Position: Q4 2023 in Review
Denali Advisors sold out of Sensus Healthcare (SRTS) in Q4 2023, closing a stake of 18,700 shares — an estimated $51.8K sold.
Denali Advisors first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $123K in Q2 2023. 41 funds tracked by Wall St. Rank hold SRTS as of Q4 2023.
- Denali Advisors reported no remaining Sensus Healthcare position as of Q4 2023 after selling out during the quarter.
- Denali Advisors sold 18,700 Sensus Healthcare shares in Q4 2023, an estimated $51.8K.
- Denali Advisors first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
- Denali Advisors's Sensus Healthcare position peaked at $123K in Q2 2023.
- 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2023.
Based on Denali Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.